Carboplatin for injection

Carboplatin for Injection is a second-generation platinum-based antitumor drug manufactured directly by CISEN PHARMACEUTICAL CO.,LTD. to Chinese Pharmacopoeia (ChP) standards, available in 50mg and 100mg specifications with samples provided. As a cycle-nonspecific agent that acts directly on DNA to inhibit rapidly dividing tumor cells, it is used in treating ovarian cancer, small-cell and non-small-cell lung cancer, head and neck squamous cell carcinoma, esophageal cancer, testicular cancer, seminoma, bladder cancer, mesothelioma, and pediatric brain tumors, and is sold across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.